These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26301748)

  • 21. What happened to patients with RMP-resistant/MDR-TB in Zambia reported as lost to follow-up from 2011 to 2014?
    Kasapo CC; Chimzizi R; Simwanza SC; Mzyece J; Chizema E; Mariandyshev A; Lee HY; Harries AD; Kapata N
    Int J Tuberc Lung Dis; 2017 Aug; 21(8):887-893. PubMed ID: 28786797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient and health-care provider experience of a person-centred, multidisciplinary, psychosocial support and harm reduction programme for patients with harmful use of alcohol and drug-resistant tuberculosis in Minsk, Belarus.
    Harrison RE; Shyleika V; Falkenstein C; Garsevanidze E; Vishnevskaya O; Lonnroth K; Sayakci Ö; Sinha A; Sitali N; Skrahina A; Stringer B; Tan C; Mar HT; Venis S; Vetushko D; Viney K; Vishneuski R; Carrion Martin AI
    BMC Health Serv Res; 2022 Sep; 22(1):1217. PubMed ID: 36180873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "When Treatment Is More Challenging than the Disease": A Qualitative Study of MDR-TB Patient Retention.
    Shringarpure KS; Isaakidis P; Sagili KD; Baxi RK; Das M; Daftary A
    PLoS One; 2016; 11(3):e0150849. PubMed ID: 26959366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Provider reported barriers and solutions to improve testing among tuberculosis patients 'eligible for drug susceptibility test': A qualitative study from programmatic setting in India.
    Shewade HD; Kokane AM; Singh AR; Parmar M; Verma M; Desikan P; Khan SN; Kumar AMV
    PLoS One; 2018; 13(4):e0196162. PubMed ID: 29677210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 'I cry every day': experiences of patients co-infected with HIV and multidrug-resistant tuberculosis.
    Isaakidis P; Rangan S; Pradhan A; Ladomirska J; Reid T; Kielmann K
    Trop Med Int Health; 2013 Sep; 18(9):1128-1133. PubMed ID: 23837468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?
    Benbaba S; Isaakidis P; Das M; Jadhav S; Reid T; Furin J
    PLoS One; 2015; 10(12):e0144936. PubMed ID: 26713873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The making of a public health problem: multi-drug resistant tuberculosis in India.
    Engel NC
    Health Policy Plan; 2013 Jul; 28(4):375-85. PubMed ID: 22865835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse drug reactions and risk factors for discontinuation of multidrug-resistant tuberculosis regimens in Gujarat, western India.
    Rupani MP; Dave JD; Parmar VB; Singh MP; Parikh KD
    Natl Med J India; 2020; 33(1):10-14. PubMed ID: 33565479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of providing counselling and financial support to patients receiving treatment for multi-drug resistant TB: mixed method qualitative and pilot intervention studies.
    Baral SC; Aryal Y; Bhattrai R; King R; Newell JN
    BMC Public Health; 2014 Jan; 14():46. PubMed ID: 24438351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study.
    Kassa GM; Teferra AS; Wolde HF; Muluneh AG; Merid MW
    BMC Infect Dis; 2019 Sep; 19(1):817. PubMed ID: 31533661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients' experiences in the era of rapid molecular diagnostic tests.
    Naidoo P; van Niekerk M; du Toit E; Beyers N; Leon N
    BMC Health Serv Res; 2015 Oct; 15():488. PubMed ID: 26511931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidrug-resistant tuberculosis patients' views of interventions to reduce treatment loss to follow-up.
    Tupasi T; Garfin AM; Mangan JM; Orillaza-Chi R; Naval LC; Balane GI; Basilio R; Golubkov A; Joson ES; Lew WJ; Lofranco V; Mantala M; Pancho S; Sarol JN; Blumberg A; Burt D; Kurbatova EV
    Int J Tuberc Lung Dis; 2017 Jan; 21(1):23-31. PubMed ID: 28157461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between social support, treatment interruption and treatment outcome in patients with multidrug-resistant tuberculosis in China: a mixed-methods study.
    Yin J; Wang X; Zhou L; Wei X
    Trop Med Int Health; 2018 Jun; 23(6):668-677. PubMed ID: 29691959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rifampicin-resistant tuberculosis patients in Myanmar in 2016: how many are lost on the path to treatment?
    Htet KKK; Soe KT; Kumar AMV; Saw S; Win Maung HM; Myint Z; Khine TMM; Aung ST
    Int J Tuberc Lung Dis; 2018 Apr; 22(4):385-392. PubMed ID: 29562985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It.
    Shringarpure KS; Isaakidis P; Sagili KD; Baxi RK
    PLoS One; 2015; 10(7):e0132543. PubMed ID: 26167891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review.
    Thomas BE; Shanmugam P; Malaisamy M; Ovung S; Suresh C; Subbaraman R; Adinarayanan S; Nagarajan K
    PLoS One; 2016; 11(1):e0147397. PubMed ID: 26807933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Task-shifting directly observed treatment and multidrug-resistant tuberculosis injection administration to lay health workers: stakeholder perceptions in rural Eswatini.
    Peresu E; Heunis JC; Kigozi NG; De Graeve D
    Hum Resour Health; 2020 Dec; 18(1):97. PubMed ID: 33272307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for unfavourable treatment outcomes among rifampicin-resistant tuberculosis patients in Tajikistan.
    Makhmudova M; Maxsumova Z; Rajabzoda A; Makhmadov A; van den Hof S; Mirtskhulava V
    Int J Tuberc Lung Dis; 2019 Mar; 23(3):331-336. PubMed ID: 30871664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barriers to access and adherence to tuberculosis services, as perceived by patients: A qualitative study in Mozambique.
    De Schacht C; Mutaquiha C; Faria F; Castro G; Manaca N; Manhiça I; Cowan J
    PLoS One; 2019; 14(7):e0219470. PubMed ID: 31291352
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.